Clinical Trials Directory

Trials / Completed

CompletedNCT00743574

Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Yale University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The investigators conducted a prospective un-blinded pilot study of Vitamin D plus Calcium (Ca) supplementation in overweight (BMI \> 27) premenopausal women diagnosed with Polycystic Ovarian Syndrome (PCOS), as defined by the Rotterdam Criteria, 2003, and who were deficient in vitamin D as reflected by serum 25-hydroxy (25-OH) vitamin D (serum levels \< 20 ng/mL).

Detailed description

We had hypothesized that in women with PCOS, administering optimal daily doses of vitamin D3, as recommended by the National Academy of Sciences, 2000IU Cholecalciferol and 1000mg of calcium, both per oral (PO), over a three month period will improve their metabolic picture, and possibly hormone profile. Over the course of the trial, after the first 5 subjects had completed 3 month intervention,we observed that daily 2000IU D3 dosing regime was inadequate in normalizing vitamin D status in the study population; the dosing regimen was therefore modified to include weekly supplementation with 50,000IU D2 in addition to daily dosing with 2000IU D3.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin D2 (Ergocalciferol)50,000IU (or 1 tablet), PO, monthly (supplements to be taken for three months)
DRUGMedroxyprogesterone (Provera)10mg, PO, daily for ten days
DIETARY_SUPPLEMENTVitamin D3 (Cholecalciferol)2,000IU (or 2 tablets), PO, daily (supplements taken for three months)
DIETARY_SUPPLEMENTElemental Calcium1,000mg (or 2 tablets), PO, daily (supplements taken for three months)

Timeline

Start date
2008-08-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2008-08-29
Last updated
2021-08-13
Results posted
2013-07-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00743574. Inclusion in this directory is not an endorsement.